Boeing Shares Jump 7%, Defense Arm Posts 21% Growth and $86B Backlog
BA•Boeing shares climbed 7% over four days since SpaceX’s IPO, outpacing newer space stocks on strength in legacy aerospace. Its defense arm posted 21% revenue growth with $9B in orders and an $86B backlog, while regulators advance approval of the 737 MAX 7 and MAX 10.
1. Stock Outperformance in Legacy Aerospace
Over the four days following SpaceX’s initial public offering, Boeing shares rose about 7%, as investors favored established aerospace and defense names. This performance contrasts with a downturn among newer space-focused firms, highlighting renewed interest in legacy contractors.
2. Defense Unit Growth
Boeing’s defense division achieved 21% year-over-year revenue growth, secured $9 billion in new contracts and built an $86 billion order backlog. These metrics bolster cash flow visibility and support the company’s broader recovery strategy.
3. 737 MAX Approval Progress
Regulators in the U.S. and Europe are nearing approval for the Boeing 737 MAX 7 and MAX 10 variants. Approval will clear the path for new deliveries, potentially boosting commercial backlog and revenue later this year.
